查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032691

生物技術試劑市場報告：按技術、應用和地區分類（2026-2034 年）

Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年全球生物技術試劑市場規模達982.157億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到1,802.466億美元，2026年至2034年的複合年成長率（CAGR）為6.77%。該市場正經歷強勁成長，其促進因素包括研發投入的增加、醫療診斷和藥物開發需求的成長、慢性病和遺傳病患疾病率的上升，以及生產和自動化技術的快速進步。

生物技術試劑市場趨勢：

生技領域研發支出增加

政府和私營部門在生技領域研發投入的增加，正在推動生技試劑產業的成長。這項投資源於人們對生物技術在醫療保健、農業和環境保護等領域解決方案的巨大潛力的認可。資金的增加也使得更廣泛、更深入的研究項目得以開展，從而帶動了對用於更廣泛實驗和製程的試劑的需求成長。例如，根據印度品牌股權基金會（IBEF）發布的最新2024年報告，印度生物技術部（DBT）在2023-24會計年度聯邦預算中獲得了1.627億美元（134.5億盧比）的撥款，用於促進研發、農業生物技術及其他領域的發展。

慢性病和遺傳疾病增加

慢性病和遺傳性疾病的日益增加正推動生物技術產業開發新型和改進的診斷和治療方案。根據美國疾病管制與預防中心（CDC）的報告顯示，美國十分之六的成年人患有慢性病，十分之四的成年人患有兩種或兩種以上的慢性病。在印度，約21%的老年人報告至少患有一種慢性病；農村地區老年人的比例為17%，都市區老年人的比例為29%。高血壓和糖尿病約佔所有慢性病的68%。這種醫療保健需求推動了對生物技術試劑的需求，這些試劑對於分子層面的疾病診斷和基因治療的發展至關重要。

在製藥和醫療保健領域不斷擴展的應用

生物技術試劑對製藥業至關重要，它們廣泛應用於藥物發現、藥物基因體學和毒性測試等領域。該行業的成長也推動了生物技術試劑市場銷售額的成長。醫療保健支出的增加、基礎設施的改善以及公眾意識的提高，正推動製藥業的蓬勃發展。例如，預計到2030年，印度製藥業的規模將達到1,300億美元。此外，印度向200多個國家出口大量藥品。該國滿足了非洲超過50%的學名藥需求、美國40%的學名藥需求以及英國25%的藥品需求。英國製藥業的銷售額也達到了408億英鎊。對有效療法的需求不斷成長以及對精準診斷的日益重視，是推動生物技術試劑市場佔有率擴張的主要因素。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球生物技術試劑市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依技術分類

  • 生命科學試劑
    • 主要部分
      • PCR
      • 細胞培養
      • 血液學
      • 體外診斷試劑
      • 其他
  • 分析試劑
    • 主要部分
      • 層析法
      • 質譜分析
      • 電泳
      • 流式細胞技術
      • 其他

第7章 市場區隔：依應用領域分類

  • 蛋白質合成與純化
  • 基因表現
  • DNA和RNA分析
  • 藥物檢測
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：促進、抑制與機遇

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies Inc.
    • Beckman Coulter Inc.（Danaher Corporation）
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Lonza Group AG
    • Merck KGaA
    • Meridian Bioscience Inc.（SD Biosensor）
    • PerkinElmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112026A8220

The global biotechnology reagents market size reached USD 98,215.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,80,246.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.77% during 2026-2034. The market is experiencing robust growth, driven by increasing investment in research and development (R&D) activities, rising demand in healthcare diagnostics and drug development, the heightened prevalence of chronic diseases and genetic disorders, and rapid technological advancements in production and automation.

BIOTECHNOLOGY REAGENTS MARKET ANALYSIS:

  • Major Market Drivers: The market is driven by the increase in global healthcare demands, particularly in diagnostics and therapeutic development, which necessitates extensive use of biotechnology reagents across various applications, heightened spending on research and development (R&D), and growing cases of chronic conditions and genetic disorders.
  • Key Market Trends: There is a notable trend towards the automation of biotechnological processes, which increases the demand for specialized reagents that are compatible with automated systems, enhancing the speed and accuracy of biotechnological assays.
  • Geographical Trends: North America remains the dominant region due to its advanced research infrastructure, significant research and development (R&D) investments, and robust regulatory environment supporting biotechnology innovations. Other regions are also expanding, fueled by increased healthcare spending, rising research activities, and governmental support to boost biotechnology as a part of national development.
  • Competitive Landscape: Some of the major market players in the biotechnology reagents industry include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation, among many others.
  • Challenges and Opportunities: A major challenge in the market is the high cost and complexity that is involved in producing and maintaining high-quality reagents. However, this also presents an opportunity for market players to innovate in cost-effective production techniques and distribution strategies to make biotechnology reagents more accessible worldwide.

BIOTECHNOLOGY REAGENTS MARKET TRENDS:

Increasing Spending on Research and Development (R&D) in the Biotechnology Sector

The increase in research and development (R&D) spending within the biotechnology sector by governments and private entities is boosting the growth of the biotechnology reagents industry. This investment is driven by the recognition of biotechnology's potential to provide solutions in healthcare, agriculture, and environmental conservation. Also, increased funding allows for more extensive and intensive research projects, which, in turn, is responsible for raising the demand for reagents used in many experiments and processes. For example, in the Union Budget 2023-24, the Department of Biotechnology (DBT), India was allotted US$ 162.7 million (Rs. 1,345 crores) to promote R&D, agriculture biotechnology, and many more, according to the latest 2024 update by the India Brand Equity Foundation (IBEF).

Rising Prevalence of Chronic Diseases and Genetic Disorders

The increase in chronic diseases and genetic disorders has motivated the biotechnology industry to develop new and improved diagnostic and therapeutic solutions. 6 in 10 adults in the US are suffering from chronic diseases. And 4 out of 10 people have more than two chronic conditions, based on the report by the Centers for Disease Control and Prevention. About 21% of the older adults in India reportedly have at least one chronic disease. 17% of geriatric people in rural areas and 29% in urban areas suffer from at least one chronic disease. Hypertension and diabetes account for about 68% of all chronic diseases. This medical need is driving the demand for biotechnology reagents. They are vital in diagnosing conditions at the molecular level and creating genetic therapies.

Growing Applications in the Pharmaceutical and Healthcare Sectors

Biotechnology reagents are essential in the pharmaceutical industry as they are being utilized in drug discovery, pharmacogenomics, and toxicological testing. Growth in this sector is also contributing to the increased biotechnology reagent market revenue. The pharmaceutical sector is growing at an astonishing rate due to increased healthcare spending, better infrastructure, and greater awareness. For instance, by 2030, this sector in India is projected to grow to $130 billion. Additionally, India exports many medications to more than 200 nations. The country supplies over 50% of Africa's requirement for generics, 40% of generic demand in the US, and 25% of all medicine in the UK. Also, the pharmaceutical industry in the UK has a turnover of 40.8 billion pounds. The growing demand for effective therapeutic drugs and the rising emphasis on accurate diagnostics are key drivers of the rising biotechnology reagents market share.

BIOTECHNOLOGY REAGENTS MARKET SEGMENTATION:

Breakup by Technology:

  • Life Science Reagents
    • PCR
    • Cell Culture
    • Hematology
    • In-Vitro Diagnostics
    • Others
  • Analytical Reagents
    • Chromatography
    • Mass Spectrometry
    • Electrophoresis
    • Flow Cytometry
    • Others

As per the biotechnology reagent market analysis and outlook, the life science reagents segment is a significant part of the market, encompassing products used in molecular biology, cell biology, genetics, and other biomedical research fields. They are essential for a variety of applications, including deoxyribonucleic acid (DNA)/ribonucleic acid (RNA) synthesis and purification, protein analysis, gene expression, and cell culture operations. Moreover, the increasing focus on research and development (R&D) in genomics and proteomics, advancements in molecular diagnostics, and the rising prevalence of chronic diseases that require novel therapeutic approaches are boosting the biotechnology reagents industry demand.

Based on the biotechnology reagents market trends and overview, analytical reagents form another crucial market segment and are predominantly used in chemical analysis, quality control, and clinical diagnostics. They are vital for spectrometry, chromatography, electrophoresis, and microscopy techniques. Analytical reagents benefit from the stringent regulatory requirements for product quality and safety in industries such as pharmaceuticals, food and beverage (F&B), and environmental testing.

Breakup by Application:

  • Protein Synthesis and Purification
  • Gene Expression
  • DNA and RNA Analysis
  • Drug Testing

As per the biotechnology reagent market segmentation, the protein synthesis and purification segment addresses the high demand for specialized reagents required in various processes involved in producing and isolating specific proteins. They are crucial in biotechnological applications such as enzyme production, pharmaceuticals, research pertaining to cellular functions, and diseases. Moreover, the widespread expansion of proteomics research and the increasing importance of biologic drugs in treatments, which rely heavily on the precise synthesis and purification of proteins, is favoring the market growth.

Based on the biotechnology reagents industry research, the gene expression segment encompasses reagents used in analyzing and quantifying gene expression levels within various cell types and conditions. It is essential in research areas like developmental biology, cancer research, and genetic disorder studies, where understanding gene activity is pivotal. Moreover, rapid advances in high-throughput technologies and the growing use of gene expression in personalized medicine to tailor treatments based on an individual's genetic makeup are enhancing the biotechnology reagent market value.

The deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis segment includes reagents used in genomic studies, such as sequencing, polymerase chain reaction (PCR) amplification, and molecular diagnostics. It is critical for advancing genetic research, identifying infectious diseases, and developing genetic markers in clinical diagnostics. Furthermore, the rapid advancements in genomic technologies, decreased sequencing costs, and the broader adoption of next-generation sequencing techniques across various fields, including forensic science, oncology, and microbiology, are bolstering the market growth.

Based on the biotechnology reagent market research report, the drug testing segment involves reagents used in pharmacological research to analyze the efficacy, stability, and safety of new drug compounds. It is vital in the preclinical and clinical stages of drug development. Additionally, the increasing global pharmaceutical R&D expenditures, the rising demand for new therapeutic drugs, and stringent regulatory standards requiring comprehensive drug testing are favoring the market growth.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biotechnology reagents market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for biotechnology reagents.

According to the biotechnology reagent market forecast, North America is the largest segment, driven by robust research infrastructure, substantial investments in biotechnology and pharmaceutical sectors, and the presence of leading biotech and healthcare companies. Moreover, the strong governmental support through funding and favorable regulatory policies aimed at advancing biotechnological research and healthcare innovations is catalyzing the market growth. Additionally, the rising adoption of advanced technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR), next-generation sequencing (NGS), and personalized medicine, is boosting the market growth. Besides this, the presence of a well-established academic and research environment, coupled with collaborations between research institutes and the biotechnology industry, is enhancing the market growth.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biotechnology reagents industry include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc. ()
  • The top biotechnology reagent industry companies are engaging in a variety of strategic initiatives to strengthen their market position and drive growth. They are investing in research and development (R&D) to innovate and improve the quality, efficiency, and application range of their reagents. For instance, they are focusing on developing more specialized reagents for advanced research areas, such as genomics, proteomics, and personalized medicine. Additionally, major players are expanding their global presence through mergers and acquisitions, partnerships with biotechnological and pharmaceutical companies, and collaborations with academic and research institutions. Moreover, they are emphasizing regulatory approvals across different regions to ensure that their offerings meet the stringent standards required in critical research and clinical applications.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global biotechnology reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biotechnology reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global biotechnology reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive biotechnology reagents market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the biotechnology reagents market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biotechnology reagents market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biotechnology reagents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotechnology Reagents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Life Science Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 PCR
      • 6.1.2.2 Cell Culture
      • 6.1.2.3 Hematology
      • 6.1.2.4 In-Vitro Diagnostics
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Analytical Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chromatography
      • 6.2.2.2 Mass Spectrometry
      • 6.2.2.3 Electrophoresis
      • 6.2.2.4 Flow Cytometry
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Protein Synthesis and Purification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gene Expression
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA and RNA Analysis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 SWOT Analysis
    • 13.3.3 Becton Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 bioMerieux SA
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bio-Rad Laboratories Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Illumina Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Lonza Group AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Meridian Bioscience Inc. (SD Biosensor)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Promega Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Waters Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biotechnology Reagents Market: Major Drivers and Challenges
  • Figure 2: Global: Biotechnology Reagents Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Biotechnology Reagents Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Biotechnology Reagents Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Biotechnology Reagents Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Biotechnology Reagents (Life Science Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Biotechnology Reagents (Life Science Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Biotechnology Reagents (Analytical Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Biotechnology Reagents (Analytical Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Biotechnology Reagents (Protein Synthesis and Purification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Biotechnology Reagents (Protein Synthesis and Purification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Biotechnology Reagents (Gene Expression) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Biotechnology Reagents (Gene Expression) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Biotechnology Reagents (DNA and RNA Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Biotechnology Reagents (DNA and RNA Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Biotechnology Reagents (Drug Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Biotechnology Reagents (Drug Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Biotechnology Reagents (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Biotechnology Reagents (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: North America: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: North America: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: United States: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: United States: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Canada: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Canada: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Asia-Pacific: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Asia-Pacific: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: China: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: China: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Japan: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Japan: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: India: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: India: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: South Korea: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: South Korea: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Australia: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Australia: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Indonesia: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Indonesia: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Others: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Europe: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Europe: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Germany: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Germany: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: France: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: France: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United Kingdom: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United Kingdom: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Italy: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Italy: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Spain: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Spain: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Russia: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Russia: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Latin America: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Latin America: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Brazil: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Brazil: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Mexico: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Mexico: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Middle East and Africa: Biotechnology Reagents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Middle East and Africa: Biotechnology Reagents Market: Breakup by Country (in %), 2025
  • Figure 69: Middle East and Africa: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Global: Biotechnology Reagents Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Biotechnology Reagents Industry: Value Chain Analysis
  • Figure 72: Global: Biotechnology Reagents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biotechnology Reagents Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Biotechnology Reagents Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Biotechnology Reagents Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Biotechnology Reagents Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Biotechnology Reagents Market: Competitive Structure
  • Table 6: Global: Biotechnology Reagents Market: Key Players